Reuma.pt Projects

 

Ongoing research projects Approval date
PROSAS STUDY – Persistence, Effectiveness and Real-World Outcomes in SpondylArthritis patients treated with Secukinumab - view 2019-04-07
PREDICT - Personalized therapy for RhEumatic DIseases via machine learning - view 2019-03-21
Determinants of happiness and quality of life in people with systemic sclerosis: a structural equation modelling approach - view 2019-01-18
Demyelinating diseases in patients treated with tumor necrosis factor inhibitors for rheumatic diseases - view 2018-11-19
Early retirement attributed to Rheumatoid Arthritis and its predictors - view 2018-11-14
Safety and effectiveness of biologic Disease-Modifying Antirheumatic Drugs in elderly patients with rheumatoid arthritis - view 2018-10-27
Efficacy and Safety of Belimumab in the treatment of Systemic Lupus Erythematosus: a Prospective Multicenter Study - view 2018-09-13
Remission and low disease activity matrix tool: results in real- world Rheumatoid Arthritis patients under golimumab - view 2018-09-10
Predictive factors of relapse, in patients with JIA in remission, after discontinuation of disease-modifying antirheumatic drugs - view 2018-08-15
Effectiveness, safety, quality of life, costs and persistence of biosimilar etanercept compared to reference etanercept in juvenile idiopathic arthritis patients – data from the Portuguese register Reuma.pt - view 2018-06-29
"PRO Reuma Initiative": collecting patient-reported outcomes using touchscreen technology - view 2018-06-17
Comparing disease features and outcomes in patients with membranous and proliferative lupus nephritis - view 2018-06-16
Juvenile idiopathic arthritis in Portugal and Brazil: a comparative study - view 2018-06-09
Impact of the implementation of biosimilars in the treatment of different rheumatic diseases perceived by the patients and by society (repercussion in Patient Reported Outcomes and economic costs) - view 2018-06-08
Variation in patient-reported outcomes for patients with Inflammatory Rheumatic diseases: evidence from Portugal - view 2018-05-16
Validation of Juvenile Spondyloarthritis Disease Activity Index (JSPADA) in a prospective cohort of Portuguese patients with juvenile spondyloarthritis - view 2018-04-29
Autoinflammatory Diseases: analysis based on The Rheumatic Diseases Portuguese Register - view 2018-04-25
Mapping from the Ankylosing Spondylitis Disease Activity Score (ASDAS) to EQ5D in patients with Axial Spondyloarthritis (axSpA) - view 2018-04-12
Neoplasms and systemic inflammatory rheumatic diseases - view (Portuguese only) 2018-03-18
Predictors of skin score change in systemic sclerosis: a Reuma.pt analysis - view 2018-03-18
Comparative long-term effectiveness and safety of switching to alternative tumour necrosis factor antagonists, tocilizumab or rituximab in patients with rheumatoid arthritis and inadequate response to a first-line TNF inhibitor - view 2017-10-06
Pattern of drug use in systemic lupus erythematosus and reasons for drug discontinuation in real life clinical practice - view 2017-07-07
Biological therapy in women with immune-mediated inflammatory rheumatic diseases: influence on pregnancy outcomes - view 2017-06-19
Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant? - view 2017-04-19
Adult outcomes of Juvenile Idiopathic Arthritis - view 2017-02-04
Efficacy and safety of biosimilar infliximab CT-P13 compared to originator infliximab in rheumatoid arthritis and axial spondyloarthritis patients - view 2017-01-19
Eligibility criteria for TNFi therapy in axSpA: BASDAI vs ASDAS - view 2016-09-15
RAID - The potential role of the "Rheumatoid Arthritis Impact of Disease" score in the management of RA - view 2016-02-02
Portuguese Early Arthritis Cohort - view (Portuguese only) 2015-05-14
Biologics discontinuation in RA and SpA : Retrospective analysis of reasons for discontinuation and outcome - view 2015-03-25
Tuberculosis risk and prevention in Rheumatic Patients Treated with Biological Therapy - view 2014-04-06
Influence of Body Mass Index in Response to Biologic therapy in Rheumatoid Arthritis - view 2014-01-03

Closed research projects Approval date
Interstitial lung disease in scleroderma patients - view 2017-08-10
Effectiveness and safety assessment of biological agents in Portuguese patients with juvenile idiopathic arthritis - view (Portuguese only) 2016-09-29
Real World Effectiveness of Switching between tumor necrosis factor inhibitors (TNFi) in Psoriatic Arthritis – EXCHANGE PsA - view 2016-06-02
EARLY PsA – Effectiveness of early Adalimumab therapy in psoriatic arthritis patients from Reuma.pt, the Rheumatic Diseases Portuguese Register, Portuguese RheumatoLogy SocietY (SPR) - view 2015-12-03
Drug survival analysis of biologic agents in rheumatoid arthritis and predictors of drug discontinuation in real world clinical practice - view 2015-08-27
GO-REAL - Real-life effectiveness of golimumab in biologic-naïve patients with rheumatoid arthritis - view 2015-02-28
Reuma.pt/ Vasculitis: The Portuguese Vasculitis Register - view 2015-01-23
Predictors of response to TNF-α blockers in patients with polyarticular psoriatic arthritis - view 2014-11-23
Disease course and adult outcomes of childhood-onset rheumatic diseases - view 2014-06-10
Lupus eritematoso sistémico em Portugal: Caracterização de subpopulações com início precoce e tardio de doença - view (Portuguese only) 2014-01-25
Physicians' attitudes in serologically active clinically quiescent systemic lupus - view 2014-01-10
Projecto T2T Portugal: T2T Monitor (versão actualizada) - view 2014-01-07
Drug survival and predictive factors for retention of TNF-α blockers in patients with ankylosing spondylitis - view 2014-01-03
Damage assessment and its association with clinical and laboratory risk factors of patients with SLE - view (Portuguese only) 2013-07-09
A comparison of sensitivity between ACR 1997 and SLICC 2012 for SLE - view (Portuguese only) 2013-02-12
The Reality of Juvenile Idiopathic Arthritis in Portugal - view (Portuguese only) 2012-10-14
The performance of the ASDAS in patients under biological therapies - view 2011-04-04
Addendum to protocol - The performance of the ASDAS in patients under biological therapies - view 2011-04-04
Project GWAS SPR - view 2011-03-09